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I read the paper “Resveratrol Levels and All-Cause Mortality in
Older Community-Dwelling Adults” by Semba et al. (JAMA Intern.
Med. 2014; 174(7):1077e1084) [1], where the authors want to
determine whether resveratrol levels achievedwith diet are associ-
atedwith inﬂammation, cancer, cardiovascular disease, andmortal-
ity in humans. In this paper, the authors concluded as “In older
community-dwelling adults, total urinary resveratrol metabolite
concentration was not associated with inﬂammatory markers, car-
diovascular disease, or cancer or predictive of all-cause mortality.” I
also read a review “Resveratrol Does Not Reduce CVD Risk, Prolong
Life”. It says “In terms of patient recommendations, Semba offered a
simple one, that patients can continue to enjoy red wine in moder-
ation, but it isn't going to help them live longer or protect them
against heart disease and cancer.”
This research is very interesting. However, from a statistical
point of view, I do not think Dr. Semba et al. can have that strong
statement “In older community-dwelling adults, total urinary
resveratrol metabolite concentration was not associated with in-
ﬂammatory markers, cardiovascular disease, or cancer or predictive
of all-cause mortality”. Based on the analysis in the paper, it is sta-
tistically wrong to have this strong statement or give the recom-
mendation “patients can continue to enjoy red wine in
moderation, but it isn't going to help them live longer or protect
them against heart disease and cancer”. When P-value is small
(usually < 0.05), we can say we have the evidence to reject the
null hypothesis and have the conclusion of association. But when
the P-value is large, we can only say we do not have the evidence
to reject the null hypothesis, but we cannot say we have proved
the null hypothesis (no association). For example, when a study
does not have enough sample size, we can have large P-value,
evenwrong trend when the association is real. Unfortunately, there
is no sample size or power calculation in this paper. However, in the
discussion section, the authors mentioned “a much larger sample
size would be needed to detect the association”. Overall, I think
the authors have made a fundamental statistical error in selling
their ﬁndings.http://dx.doi.org/10.1016/j.conctc.2015.08.004
2451-8654/© 2015 The Author. Published by Elsevier Inc. This is an open access article uCan we prove no association? Statistically, it can never be done.
With a large sample size (tending to inﬁnity), one can always ﬁnd a
very small effect size (tending to 0) to show a statistically non-
signiﬁcant result. However, is this small effect size clinically impor-
tant? We can prove that not having Resveratrol is clinical equiva-
lence to having Resveratrol or not having Resveratrol is Not
CLINICALLY SIGNIFICANTLY worse than having Resveratrol.
Suggests: the authors can provide a one-sided 95% CI for the HR.
Based on the number provided in the paper, the CI is (0, 1.11), which
implies that the study can rule out a beneﬁt of 10% or more reduc-
tion in mortality for having an elevated resveratrol level. Therefore,
the study suggests that high resveratrol level is unlikely to be asso-
ciated with 10% or more reduction inmortality. A larger sample size
can provide a more accurate estimate.Acknowledgement
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